On a sugar high: Role of O-GlcNAcylation in cancer

Giang Le Minh1, Emily M Esquea1, Riley G Young1

  • 1Department of Biochemistry and Molecular Biology, Drexel University College of Medicine, Philadelphia, Pennsylvania, USA.

PubMed

Insights

O-GlcNAcylation, a protein modification regulated by O-GlcNAc transferase (OGT), is elevated in cancer. This review explores the latest findings on OGT and O-GlcNAc

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Aberrant glycosylation is increasingly recognized for its role in cancer progression.
  • O-GlcNAcylation, a post-translational modification, is gaining attention in cancer research.
  • O-GlcNAc transferase (OGT) catalyzes O-GlcNAcylation, linking nutrient availability to cancer signaling.

Purpose of the Study:

  • To review recent findings on the involvement of OGT and O-GlcNAc in cancer.
  • To highlight the significance of O-GlcNAcylation as a potential therapeutic target.

Main Methods:

  • Literature review of recent advancements in cancer research.
  • Analysis of studies investigating OGT and O-GlcNAc in cancer progression.

Main Results:

  • O-GlcNAcylation and OGT are significantly elevated in various cancers.
  • Both OGT and O-GlcNAc play crucial roles in regulating key cancer hallmarks.
  • O-GlcNAcylation influences cancer cell survival, proliferation, and progression.

Conclusions:

  • OGT and O-GlcNAc are critical regulators of cancer progression.
  • Targeting OGT and O-GlcNAcylation presents a promising therapeutic strategy for cancer.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Oligosaccharide Assembly01:24

Oligosaccharide Assembly

Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
2.9K
Proteoglycans01:05

Proteoglycans

Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
3.9K
Protein Glycosylation01:25

Protein Glycosylation

Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
7.0K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer-Critical Genes I: Proto-oncogenes01:33

Cancer-Critical Genes I: Proto-oncogenes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.9K